Find Academic Supervisors

• Bioethics
• Clinical Ethics
• Health Care Ethics
• +3 more

Catherine Bert is a Researcher affiliated with the University of Namur (UNamur), based in the Center for Vulnerabilities and Societies Transitions within the Philosophical Space of Namur. She holds a Doctorate in Philosophy (UNamur) and multiple diplomas in Sociology, International Relations, and Comparative Politics from Université catholique de Louvain (UCL). Her academic roles include being a Professor of Philosophy, Ethics, Anthropology, and Sociology at the IES Parnasse-Deux-Alice in Brussels, a member of the ethics committee at CHR de la Haute Senne, and an editorial board member of the journal Les politiques sociales . Research Interests: Dr. Bert specializes in clinical ethics, bioethics, and pandemic-related healthcare ethics. Her work intersects with sociological and anthropological perspectives, focusing on solidarity practices, care ethics, and gender-based violence in medical contexts. She actively contributes to the United Nations Sustainable Development Goals, particularly in eradicating poverty and promoting health equity. Projects & Activities: She has led or collaborated on projects like the 'Universality of Values in Bioethics' and 'Virtue Ethics in Care Practices Analysis'. Her research spans ethical dilemmas in healthcare, including reproductive rights and pandemic response. She frequently participates in workshops, conferences, and colloquia on ethics and healthcare, such as the 'Certificat interUniversitaire en Éthique des Soins de Santé (CUESS)'. Publications: Her recent work addresses solidarity initiatives, crisis care ethics, and gender violence in reproductive healthcare. She also explores molecular mechanisms in skin diseases, including fungal infections and epidermal barrier dysfunction. Affiliations & Roles: Beyond academia, she advises on ethical committees and editorial boards, emphasizing translational ethics into policy and practice.

Eduardo N. ChiniView profile

Professor

• Metabolism
• NAD Metabolism
• Aging
• +11 more

Eduardo N. Chini, M.D., Ph.D., is a Professor at Mayo Clinic with primary and joint appointments in the Department of Anesthesiology and Perioperative Medicine and the Department of Cancer Biology. He is based in Rochester, Minnesota, and leads a research program focused on NAD metabolism, aging, and their roles in diseases such as cancer, obesity, and kidney disease. Education: BS in Biology, Centro Educacional de Niteroi-RJ MD, Universidade do Rio de Janeiro PhD in Biological Chemistry, Universidade do Rio de Janeiro Fellow, Department of Physiology and Biophysics, Mayo Clinic Resident in Anesthesiology, Mayo Clinic College of Medicine Research Interests: Eduardo N. Chini's research investigates the central role of nicotinamide adenine dinucleotide (NAD) in cellular metabolism, aging, and disease. His lab has made foundational discoveries in NAD catabolism, identifying CD38 as the primary enzyme regulating NAD levels in mammals. His work explores SIRT1 regulation via CD38 and DBC1, NAD metabolism in cancer, and its implications in polycystic kidney disease. He is particularly interested in how NAD signaling influences aging, metabolic syndrome, and organ dysfunction. Recent Research Trends: His recent publications (2023–2025) reveal a strong focus on the role of CD38 in aging, immune function, and tissue metabolism. Key themes include NAD+ depletion triggering inflammatory responses, CD38 inhibition as a therapeutic strategy for cardiotoxicity and metabolic aging, and the interplay between senescence, stem cell function, and mitochondrial health. His work increasingly integrates translational models with molecular mechanisms in aging and cancer. Scientific Awards: Florida Investigator of the Year, Mayo Clinic (2024) Glenn/AFAR Breakthroughs in Gerontology Award (2007) Edward C. Kendall Award, Mayo Clinic Alumni Association (2002) Directors Award for Aging Research, Kogod Center on Aging (2018) Distinguished Scientist Seminar Series, Georgetown Medical School (2022) Grants and Leadership: Dr. Chini is a co-Principal Investigator on multiple NIH-funded grants, including projects on CD38 in scleroderma, CLL, and male reproductive aging. He is Co-Director of the Mayo Clinic Mitochondrial Care Center and Associate Director of the Robert and Arlene Kogod Center on Aging. He has served on numerous national review panels and advisory councils, including the NIH Hepatobiliary Pathophysiology Study Section and AFAR's National Scientific Advisory Council. Labs and Teams: Dr. Chini leads a research laboratory at Mayo Clinic focused on NAD metabolism and aging. His team collaborates extensively with experts in cancer biology, mitochondrial medicine, and aging research. He is affiliated with the Mayo Clinic Comprehensive Cancer Center, the Kogod Center on Aging, and the Robert M. and Billie Kelley Pirnie Translational PKD Center.

Deborah GoberdhanView profile

Associate Professor

• Cancer Biology
• Cell Growth Regulation
• mTORC1 Signaling
• +5 more

Dr. Deborah Goberdhan is an Associate Professor at the University of Oxford , affiliated with the Department of Physiology, Anatomy and Genetics (DPAG) . She leads an independent research group investigating amino acid sensing , mTORC1 signaling , and exosome-mediated communication in cancer progression using both human cancer cells and Drosophila models . She serves on the Cancer Research UK Oxford Centre Research Committee , teaches Medical and Biomedical Sciences undergraduates , and acts as Academic Public Engagement Lead for her department. Her research focuses on cell growth regulation through Proton-assisted Amino acid Transporters (PATs) , which function as 'transceptors' modulating mTORC1 activity . This work has expanded to examine exosome heterogeneity and therapeutic delivery mechanisms with support from BBSRC and Cancer Research UK . She co-founded Oxosome , the Oxford extracellular vesicle interest group , to foster interdisciplinary collaboration. Key research areas include Cancer cell communication via exosomes Amino acid signaling in tumor progression Drosophila as cancer model system Clinical collaborations with Prof Adrian L Harris , Prof Freddie C Hamdy , and Prof Clare Verrill Recent publications highlight her group's contributions to exosome biogenesis (2023), brain-targeted siRNA delivery (2021), and nutrient stress responses in cancer (2020). She actively promotes scientific communication through ISEV social media initiatives.

• Neuropharmacology
• Neuroendocrinology
• Sleep Research
• +3 more

Jessica A. Mong, PhD , is a Professor in the Department of Pharmacology & Physiology at the University of Maryland School of Medicine , where she also serves as Assistant Dean for Graduate & Post-Doctoral Studies and Director of Graduate Education for the Program in Neuroscience. Her research focuses on the neuroendocrine mechanisms underlying sex differences in sleep circuitry and the estrogenic modulation of sleep-wake cycles. Primary Appointment: Pharmacology & Physiology Administrative Title: Assistant Dean for Graduate & Post-Doctoral Studies Laboratory Director: Program in Neuroscience Research Interests: Dr. Mong's work investigates how ovarian steroids influence sleep-wake behavior through sexually differentiated neuroanatomical substrates. Key areas include: Mechanisms of estrogenic modulation in the median preoptic nucleus (MnPN) Developmental programming of sex differences in sleep sensitivity Translational studies using rodent and nonhuman primate models of menopause Functional significance of hormonal influences on sleep quality and recovery Scientific Trends: Her recent publications (2023-2025) emphasize: Role of KCNMA1 channelopathy in sleep regulation Adenosinergic signaling in MnPN Translational menopause models Estrogen's protective effects against noise-induced hearing loss Sex-dependent responses to kynurenine pathway challenges Awards & Appointments: NIH BIRCWH Scholar (Building Interdisciplinary Research Careers in Women's Health) Co-Chair, Society for Women’s Health Research Interdisciplinary Research Network on Sex-Differences in Sleep Health NIH/NHLBI R01 HL129138 grant recipient Education & Training: B.S., Biology, Gettysburg College (1987-1991) Ph.D., Neuropharmacology, University of Maryland Baltimore (1994-2000) NIH Postdoctoral Fellowship in Endocrinology, Rockefeller University (2000-2003)

Andrew GodwinView profile

Professor

• Molecular Oncology
• Precision Medicine
• Biomarker Discovery
• +3 more

Andrew Godwin is a Professor at the University of Kansas Medical Center , where he serves as the Chancellor’s Distinguished Chair in Biomedical Sciences and Director of Molecular Oncology in the Department of Pathology and Laboratory Medicine. He is also the Deputy Director of the NCI-designated University of Kansas Cancer Center and the Founding Director of the Kansas Institute for Precision Medicine and Biospecimen Shared Resource . Dr. Godwin is a leader in translational research and precision medicine , with a focus on molecular oncology , biomarker discovery , and genomic diagnostics . His work bridges basic and clinical science to improve cancer patient care, particularly in ovarian cancer , Ewing sarcoma , and breast cancer . He has contributed over 230 ovarian cancer-related publications and pioneered studies linking the PI3K/AKT pathway to cancer treatment targets. His research program encompasses liquid biopsies using extracellular vesicles , molecular therapeutics , companion diagnostics , and clinical trial validation . He leads the Biomarker Discovery Laboratory and has secured over $250M in extramural funding , including a $11.4M NIH grant for precision medicine initiatives. His team has developed CELLSEARCH® , the first FDA-cleared test for circulating tumor cells. Notable awards include the Dolph C. Simons, Sr. Higuchi Award (2020), Outstanding Mentorship in Pathology Award (2024), and multiple mentoring accolades from KU. He has mentored over 150 trainees across career stages and leads a multidisciplinary lab with expertise in genomics , proteomics , and bioengineering . Academic Roles: Chancellor’s Distinguished Chair in Biomedical Sciences Director, Molecular Oncology, Pathology and Laboratory Medicine Deputy Director, KU Cancer Center Founding Director, Kansas Institute for Precision Medicine Adjunct Professor, Bioengineering Program, University of Kansas Scientific Awards: KUMC Achievement Award for mentoring postdocs (2014) Chancellor’s Club Award for Research (2018) Dolph C. Simons, Sr. Higuchi Award (2020) KU Excellence in Mentoring Award (2021) Outstanding Mentorship in Pathology (2024) Key Research Themes: Extracellular vesicles as liquid biopsy tools Molecular mechanisms of sarcoma and breast cancer Genomic diagnostics and precision oncology Clinical trial biomarker validation Biospecimen repository leadership

• Biological Aging
• Cancer Survivorship
• Sleep Science
• +5 more

Judith E Carroll, PhD, is an Adjunct Associate Professor in the Department of Psychiatry and Biobehavioral Sciences at UCLA's School of Medicine, where she holds the George F. Solomon Professorship of Psychobiology. She directs the Aging Biology & Behavior Lab and co-leads the Infrastructure for Research in Equity, Aging, Cancer and Health initiative. Her research bridges psychoneuroimmunology, geroscience, and oncology, with continuous NIH funding since 2013. Education: PhD in Biological & Health Psychology, University of Pittsburgh (2010) MA in Biopsychology & Aging, Sonoma State University (2003) BA in Psychology, Sonoma State University (2002) Her research examines biological mechanisms linking stress, sleep, and aging in cancer populations. Primary interests include: Accelerated aging biomarkers in breast cancer survivors Sleep health interventions to reverse cellular aging Impact of early-life adversity on lifelong health trajectories Social determinants of cognitive decline in oncology Recent publications (2023-2025) demonstrate: Dominant focus on epigenetic aging and inflammation in oncology Longitudinal studies of cancer-related cognitive decline Methodological innovation in transcriptomic biomarker discovery Health disparities framework across 80% of publications Awards: American Psychosomatic Society Young Scholar Award (2012) American Sleep Medicine Foundation Bridge to K Award (2013) American Cancer Society Research Scholar Award (2015) STOP CANCER Career Development Award (2016) PNIRS Robert Ader New Investigator Award (2019) Active Grants (NIH): R01AG082348: Patterns of Biological Aging in Cancer Survivors (MPI, 2023-2028) R56AG068086: Heterogeneity in Aging Among Breast Cancer Survivors (PI, 2021-2022) R01CA237535: Accelerated Aging in Breast Cancer (PI, 2020-2023) She mentors through the TLC (Thinking and Living with Cancer) Study consortium involving 15+ institutions. Leads the Aging Biology & Behavior Lab researching stress-sleep-aging mechanisms and co-directs the Infrastructure for Research in Equity, Aging, Cancer and Health (REACH) initiative, fostering multi-institutional collaborations on health disparities.

• Exercise Physiology
• Bone Metabolism
• Muscle Metabolism
• +5 more

Professor Craig Sale holds the position of Professor of Human Physiology and Nutrition at Manchester Metropolitan University (MMU) and previously led research initiatives at Nottingham Trent University (NTU). He specializes in investigating exercise and nutrition interventions, particularly focusing on bone and muscle adaptations. His roles include Co-Lead of NTU’s Health & Wellbeing Strategic Research Theme, Director of the SHAPE Research Centre, and REF Unit of Assessment Coordinator for UoA C24. His research spans bone metabolism, muscle performance, genetics, sports nutrition, biomechanics, and environmental physiology, with a commitment to impactful real-world applications. His research has addressed topics such as beta-alanine supplementation for exercise performance, diet/exercise interventions for bone health in athletes, and the biological actions of carnosine. He has supervised 17 completed PhD students and currently guides 8 more. His awards include Fellowship in the American College of Sports Medicine (ACSM) and a Section Editor role at the European Journal of Sports Sciences. Recent work emphasizes bone biomarker responses to exercise, myocardial carnosine roles, and pregnancy’s legacy on athletic performance.

Ian A.E. ButtsView profile

Associate Professor

• Aquatic Sciences
• Fish Reproduction
• Aquaculture
• +2 more

Dr. Ian A.E. Butts is an Associate Professor at Auburn University's School of Fisheries, Aquaculture & Aquatic Sciences. His research program addresses critical challenges in aquatic reproduction, focusing on gamete biology, environmental physiology, and aquaculture biotechnology. Research interests center on reproductive physiology of aquatic species, cryopreservation techniques, environmental impacts on fish reproduction, and innovative breeding technologies. His work spans diverse species including catfish, oysters, goldfish, and European eel, with emphasis on improving aquaculture sustainability through advanced reproductive management. Publications demonstrate consistent focus on gamete quality assessment, cryopreservation biomarkers, xenogenesis, and environmental stressors' effects on reproductive success. Recent work explores transcriptomic responses to temperature variations, salinity effects on bivalve reproduction, and molecular biomarkers for sperm quality evaluation.

• Immunology
• Biochemistry and Cell Biology
• Clinical Sciences
• +3 more

Professor Daniel Davis MBE FMedSci is the Head of the Department of Life Sciences and Professor of Immunology at Imperial College London. He holds affiliations with the Institute of Chemical Biology, the CDT in Chemical Biology: Innovation in Life Sciences (as a supervisor), and research groups in Immunology and Molecular Mechanisms of Disease. His academic journey includes a doctorate in Physics from Harvard University and prior roles as Director of Research at the Manchester Collaborative Centre for Inflammation Research (University of Manchester). His research focuses on nanoscale biology of immune cell interactions, employing advanced microscopy techniques to study immune synapse formation, cytotoxicity mechanisms, and immunological regulation. Notable contributions include elucidating how immune cells use adhesion, signaling, and structural reorganization to target pathogens and cancer cells. Professor Davis has authored four popular science books, including Self Defence: A Myth-Busting Guide to Immune Health (2025), The Beautiful Cure (2018), and The Compatibility Gene (2014), which bridge public understanding of immunology and biology. His work has been recognized with prestigious awards such as the Royal Society Science Book Prize and the Prose Award. His articles span topics like NK cell heterogeneity, gene therapy for neurological disorders, and super-resolution microscopy applications. Grants and collaborations include work on AAV-based gene therapies and immunomodulatory drug development. Davis actively engages in public science communication through festivals, media outlets (e.g., BBC, Guardian), and international speaking engagements. His research labs at Imperial College focus on interdisciplinary approaches, combining biophysics, genetics, and clinical applications to advance immunology and translational medicine.

• Epigenetic Mechanisms
• Drug Discovery
• Target Discovery
• +7 more

Professor Udo Oppermann serves as Professor of Molecular Biology and Director of Laboratory Sciences at the Institute of Musculoskeletal Sciences, Botnar Research Centre, University of Oxford. He is also Deputy Director of the Oxford Centre of Translational Myeloma Research and a fellow at St Catherine's College. His educational background includes a Diploma in Human Biology (1990) and PhD in Pharmacology and Toxicology (1994), both earned with distinctions from Philipps University Marburg. Prior academic appointments include Associate Professor at Karolinska Institutet (until 2004) and sabbatical work at Yale University. Research focuses on epigenetic mechanisms in disease through drug and target discovery using systems biology and single-cell approaches . Key disease targets include metabolic disorders, inflammatory conditions, and malignant diseases—particularly multiple myeloma and secondary bone cancers. His group pioneers chemical biology applications in primary tumor microenvironments. Current funding sources include Cancer Research UK, Innovate UK, EPSRC, Royal Society-Newton Fund, Bristol Myers Squibb, Bayer Healthcare, GlaxoSmithKline, Blood Cancer UK, and Leducq Foundation. Notable research trends show increasing emphasis on epigenetic regulation in immune cells (2020-2024), single-cell technologies for myeloma (2022-2024), and translational applications of chromatin modifiers (2016-2019). Recent work integrates metabolomics with epigenetic mechanisms in gynecological and hematological disorders. He supervises doctoral research including Singh K.'s 2024 thesis on sonodynamic therapy mechanisms. Leadership roles encompass directing Oxford's Molecular Laboratory Sciences division and co-leading translational myeloma research initiatives.

Ai-ris Yonekura CollierView profile

Assistant Professor

• Maternal-Fetal Medicine
• Immunology in Pregnancy
• Infectious Diseases in Pregnancy
• +3 more

Dr. Ai-ris Yonekura Collier serves as Assistant Professor in Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School and Staff Physician in the Department of Obstetrics and Gynecology at Beth Israel Deaconess Medical Center (BIDMC). She concurrently holds a Physician-Scientist position at BIDMC's Center for Virology and Vaccine Research (CVVR) and co-directs the Clinical Trials Unit within CVVR, establishing a critical bridge between maternal-fetal medicine and virology research. Her academic foundation includes: B.S. in Biology (Minor: Chemistry) from Massachusetts Institute of Technology (2005) M.D. from Harvard Medical School through Harvard-MIT Health Sciences & Technology Program (2011) Obstetrics & Gynecology Residency at UCLA (2011-2015) Maternal-Fetal Medicine Fellowship at BIDMC (2015-2018) Dr. Collier's research centers on maternal immune tolerance mechanisms in placental development, with dual investigative tracks: (1) Characterizing cellular immune phenotypes in pregnancy disorders like preeclampsia and fetal growth restriction, and (2) Analyzing infectious disease impacts including Zika virus and SARS-CoV-2. Her translational approach integrates longitudinal biospecimen repositories with clinical observations, emphasizing the inclusion of pregnant populations in vaccine trials. As an educator, she actively mentors trainees and advocates for policy changes in clinical trial design. Recent publications demonstrate a pronounced focus on viral immunology during the pandemic era, with 7 of 9 recent papers addressing SARS-CoV-2 variants, vaccine responses, and Mpox immunity. These works reveal consistent methodological themes: neutralization assays against emerging variants, analysis of coagulation-inflammation pathways in vaccine complications, and sensitive diagnostic approaches for prior infections. Concurrently, she maintains her foundational research in placental immunology, exemplified by cytokine studies in preeclampsia. Her scientific recognition includes: NIH Loan Repayment Program (2018-2020) Mentor Award from ACOG District I (2021) Translational Research Hubs Spark Grant Award (2022) Rookie of the Year Award at BIDMC (2016) Multiple research presentation awards from perinatal societies As Principal Investigator of the Yonekura Collier Laboratory and Co-Director of the Clinical Trials Unit, she manages substantial grant funding including NIH/NICHD support and institutional translational grants. Her leadership extends to hospital-wide initiatives like the BIDMC COVID-19 Biorepository, while her advocacy focuses on rectifying historical exclusions of pregnant individuals from clinical research. She maintains active collaborations across Harvard's immunology and virology departments. The Yonekura Collier Laboratory operates within CVVR's collaborative ecosystem, integrating with Dan Barouch's research group and the broader Harvard Medical School community. Her team combines clinical obstetric expertise with advanced immunological techniques to investigate fetal-maternal interface biology, creating a unique interdisciplinary hub for perinatal infectious disease research.

Erez RazView profile

Professor

• Cell Migration
• Germ Cell Development
• Embryonic Development
• +4 more

Professor Erez Raz serves as Director of the Institute of Cell Biology at the University of Münster and is affiliated with the Center for Molecular Biology of Inflammation (ZMBE). He is a prominent member of the Cluster of Excellence "Cells in Motion" and serves on the board of the CiM-IMPRS graduate program. His research group "AG Raz: Cell biology in vivo - Germ-cell development" investigates fundamental mechanisms of cell migration in living organisms. Professor Raz's research focuses on cell migration, cell-fate maintenance, and organogenesis within live vertebrate embryos. His laboratory primarily employs zebrafish as a model organism due to its transparent embryos that develop externally, enabling high-resolution live imaging of cellular processes. His work has revealed critical mechanisms of how cells navigate within developing organisms, with significant implications for understanding pathological conditions like cancer metastasis and inflammatory processes where cell migration becomes dysregulated. His recent publications demonstrate a sustained focus on molecular mechanisms controlling germ cell migration, including the roles of RNA-binding proteins like Dnd1, bleb formation dynamics, mitochondrial regulation of germ cell fitness, and tissue microenvironment influences on cell protrusion types. His research uniquely integrates approaches from cell biology, biophysics, genetics, and mathematical modeling to gain comprehensive insights into cellular migration dynamics. Over 100 publications spanning two decades Extensive collaborations across disciplines Methodological innovations in cell imaging and manipulation Professor Raz has successfully mentored numerous doctoral students and postdoctoral researchers, fostering interdisciplinary collaborations between biologists, physicists, mathematicians, and clinicians. His laboratory has developed innovative techniques for cell ablation, mRNA labeling, and in vivo manipulations using optical tweezers, contributing significantly to methodological advances in the field. His laboratory participates in the Multiscale Imaging Centre and the "Cells in Motion" research network, providing access to state-of-the-art imaging capabilities for studying cellular dynamics at multiple scales, from molecular interactions to whole-organism development.

Rebecca TaylorView profile

Lecturer

• Biological Resilience
• Cellular Stress Response
• Ageing
• +7 more

Rebecca Taylor is a Lecturer in Biomedicine at the School of Biological Sciences, University of East Anglia (UEA). She leads an active research group focused on biological resilience, cellular stress responses, and the molecular mechanisms linking ageing and homeostasis. She is currently accepting PhD students, indicating ongoing academic mentorship and research supervision. Research Interests: Dr. Taylor's research centers on understanding how cells and organisms maintain homeostasis under stress. Her lab investigates the secretory pathway as a central hub for stress response coordination, with a particular interest in how ageing disrupts these pathways. Key aims include identifying novel stress resistance mechanisms, understanding systemic coordination of resilience, and exploring how modulating stress pathways can influence ageing and age-related diseases. Publication Trends: Her recent work, published in journals like Nature Aging , Frontiers in Aging , and Nature Chemical Biology , shows a strong focus on model organisms (especially C. elegans ), unfolded protein response (UPR), TGF-β signaling, and the intersection of sensory perception and lifespan regulation. The research integrates molecular biology, genetics, and systems-level approaches to uncover conserved mechanisms of ageing and resilience. Scientific Recognition: While specific awards are not listed, her work has garnered significant attention, with over 3500 citations (Scopus) and an h-index of 11. Her research has been highlighted on social media platforms (X, Facebook), picked up by news outlets, and blogged about, indicating broad academic and public engagement. Mentorship and Research Output: Dr. Taylor actively supervises research, as evidenced by her co-authorship with junior researchers and her openness to PhD students. Her lab produces a steady stream of high-quality publications, including original research articles and commentaries, contributing to key discussions in ageing and stress biology. She collaborates with an international network of scientists, as shown by her co-authorship on conference reports and multi-institutional studies. Laboratory and Collaboration: The Taylor Lab operates within the School of Biological Sciences at UEA, focusing on experimental models to dissect stress response pathways. Her collaborations span multiple institutions and countries, reflecting an integrated approach to studying organismal proteostasis and ageing. The lab utilizes genetic, biochemical, and behavioral assays to explore fundamental questions in biomedicine.

Lou J. SoslowskyView profile

Professor

• Orthopaedic Biomechanics
• Tendon Research
• Ligament Research
• +3 more

Lou J. Soslowsky is the Fairhill Professor at the University of Pennsylvania, serving as Director of Orthopaedic Research, Director of Basic Science Research for the Shoulder and Elbow Service, and Vice Chair for Research in the Department of Orthopaedic Surgery at the Perelman School of Medicine. He was reappointed to the Vice Chair position in 2024, demonstrating his continued leadership role. Dr. Soslowsky is also the Founding Director of the Penn Center for Musculoskeletal Disorders (designated as a Type 1 center in 2008) and an Associate Dean for Research Integration at the Perelman School of Medicine. Dr. Soslowsky earned his B.S. (1986), M.S. (1987), M.Phil (1989), and Ph.D. (1991) in Engineering Mechanics from Columbia University, with doctoral research mentored by Van C. Mow. He later obtained a certificate in Academic Medicine Leadership from the Wharton School of the University of Pennsylvania in 2008. Dr. Soslowsky's research focuses on the biomechanics of tendons and ligaments, particularly in the shoulder and elbow. His laboratory investigates the structural, functional, and molecular properties of musculoskeletal tissues, examining how these tissues respond to injury, healing, and aging. Current projects examine collagen organization (particularly Collagen V and XI), the role of decorin and biglycan in tendon healing, exercise effects on tendon adaptation, and advanced imaging techniques for monitoring tissue changes. His work integrates engineering principles with biological approaches to understand tissue mechanics and develop therapeutic strategies for musculoskeletal disorders. His recent publications (2024-2025) demonstrate a strong focus on tendon biology and biomechanics, with particular attention to molecular regulation of tendon healing, collagen organization, and the effects of aging and mechanical loading. His research spans from basic molecular mechanisms to translational applications, often utilizing murine models to investigate tendon development, injury, and repair processes. The interdisciplinary nature of his work bridges engineering, biology, and clinical orthopaedics. Founding Director, Penn Center for Musculoskeletal Disorders (Type 1 center designation, 2008) Fellow, Institute of Aging, University of Pennsylvania Executive Committee, Department of Bioengineering, University of Pennsylvania As Director of the McKay Orthopaedic Research Laboratory, Dr. Soslowsky oversees an active research program with publications spanning from 1987 to 2025 (274 PubMed-listed publications). His laboratory serves as a hub for interdisciplinary research in orthopaedic biomechanics and tissue engineering, bringing together engineers, biologists, and clinicians to address fundamental questions in musculoskeletal science. His work has significant translational implications for understanding and treating tendon injuries, which are common clinical problems affecting millions of people.

Maria M. ViveirosView profile

Associate Professor

• Cell and Developmental Biology
• Regenerative Medicine
• Reproductive Physiology
• +3 more

Maria M. Viveiros is an Associate Professor and Assistant Department Head in the Department of Physiology and Pharmacology at the University of Georgia’s College of Veterinary Medicine. Her research integrates experimental approaches like live cell imaging, molecular biology, and genetic mouse models to study meiotic division accuracy in oocytes, genomic stability, and the effects of environmental toxicants on embryonic development. She co-leads the Dr. Viveiros’s Lab and participates in interdisciplinary programs such as the Interdisciplinary Toxicology and Regenerative Biosciences Programs. Dr. Viveiros holds a PhD in Physiology and Pharmacology from the University of Guelph (Canada), an MSc from the same institution, and a BSc from McMaster University (Canada). She coordinates multiple graduate courses, including Integrative Systems Physiology I and II (VPHY 8210 and VPHY 8250), and leads the Endocrine and Reproductive Systems I course (VETM 5194). Her research interests focus on cell and developmental biology, regenerative medicine, reproductive physiology, and toxicology. Key projects address mechanisms regulating meiotic spindle assembly, monitoring chromosome attachment, and assessing how aging and environmental factors disrupt these processes. She explores epigenetic control of oocyte maturation, centromere function, and the impact of chemicals like bisphenol on gamete and embryo health. Publications highlight her work on pericentric satellite transcription, bisphenol toxicity, and epigenetic modifiers in oogenesis. Her contributions bridge molecular and cellular mechanisms with broader implications for human health, such as Down Syndrome and pregnancy loss linked to meiotic errors. She also investigates the role of proteins like ATRX, NEDD1, and Aurora Kinase A in spindle stability and chromosome segregation.